| Absorption |
| Blood-Brain Barrier | BBB+ | 0.9709 |
| Human Intestinal Absorption | HIA+ | 0.9952 |
| Caco-2 Permeability | Caco2+ | 0.8798 |
| P-glycoprotein Substrate | Non-substrate | 0.7918 |
| P-glycoprotein Inhibitor | Non-inhibitor | 0.9679 |
| Non-inhibitor | 0.9701 |
| Renal Organic Cation Transporter | Non-inhibitor | 0.8795 |
| Distribution |
| Subcellular localization | Mitochondria | 0.7418 |
| Metabolism |
| CYP450 2C9 Substrate | Non-substrate | 0.7881 |
| CYP450 2D6 Substrate | Non-substrate | 0.9514 |
| CYP450 3A4 Substrate | Non-substrate | 0.7647 |
| CYP450 1A2 Inhibitor | Non-inhibitor | 0.5370 |
| CYP450 2C9 Inhibitor | Non-inhibitor | 0.9646 |
| CYP450 2D6 Inhibitor | Non-inhibitor | 0.9753 |
| CYP450 2C19 Inhibitor | Non-inhibitor | 0.9536 |
| CYP450 3A4 Inhibitor | Non-inhibitor | 0.9894 |
| CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.9238 |
| Excretion |
| Toxicity |
| Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.9605 |
| Non-inhibitor | 0.9851 |
| AMES Toxicity | Non AMES toxic | 0.9868 |
| Carcinogens | Non-carcinogens | 0.6389 |
| Fish Toxicity | High FHMT | 0.7505 |
| Tetrahymena Pyriformis Toxicity | High TPT | 0.9399 |
| Honey Bee Toxicity | High HBT | 0.7870 |
| Biodegradation | Ready biodegradable | 0.8653 |
| Acute Oral Toxicity | III | 0.8418 |
| Carcinogenicity (Three-class) | Non-required | 0.6339 |